BIOASTER
Thomas Ribette is an experienced professional in the field of mass spectrometry and proteomics, currently serving as an Ingénieur développement en spectrométrie de masse en protéomique at BIOASTER since November 2020, focusing on nano LC-HRMS protein analysis and DESI-MS lipid analysis. Prior roles include development of analytical methods for lipidomics and metabolomics, as well as the creation of databases and validation of sample preparation. Thomas Ribette holds a Doctorate in Chimie théorique from Université de Poitiers, where research involved biomarker analysis using miniaturized liquid systems, in a joint thesis with CNES. Additionally, previous experience includes an internship at CEA, where analytical method optimization was performed. Thomas Ribette earned a Master's degree in Chimie analytique et qualité from Université de Poitiers.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org